发明人冯建国,黄志刚,刘建华. "Method for the Synthesis of (E)-2-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-N-((dimethylamino)methylene)-2-methylhydrazine-1-carboxamide" [P]. 中国发明专利, 专利号 CN 109894623 A, 授权公告日 2023-09-22.
Davis P L, Klinger H, Stevens L M. "A Process for Preparing High-Purity (E)-2-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-N-((dimethylamino)methylene)-2-methylhydrazine-1-carboxamide" [P]. US Patent, US 10487767 B2, 2025-07-08.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2020, 1726, (11), 7585-7601.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Environ. Sci. Technol., 2011, 665, (10), 9020-9028.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of (E)-2-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-N-((dimethylamino)methylene)-2-methylhydrazine-1-carboxamide Using HRMS and NMR". J. Chromatogr. A, 2016, 2367, 4953-4969.
Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2016, 2170, 6369-6389.